FibroBiologics (FBLG) Institutional Ownership $0.66 -0.01 (-0.82%) Closing price 04:00 PM EasternExtended Trading$0.66 +0.00 (+0.21%) As of 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for FibroBiologics (NASDAQ:FBLG)Number ofInstitutional Buyers(last 12 months)21TotalInstitutional Inflows(last 12 months)$9.56MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$236.53K Get FBLG Insider Trade Alerts Want to know when executives and insiders are buying or selling FibroBiologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data FBLG Institutional Buying and Selling by Quarter FibroBiologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025AQR Capital Management LLC32,227$29K0.0%N/A0.084% 5/13/2025Cascade Financial Partners LLC260,081$234K0.0%-8.0%0.680% 5/12/2025Nuveen LLC34,540$31K0.0%N/A0.090% 4/30/2025Cerity Partners LLC93,407$84K0.0%+19.6%0.248% 2/14/2025Jane Street Group LLC61,074$122K0.0%+415.3%0.168% 2/13/2025Raymond James Financial Inc.18,642$37K0.0%N/A0.051% 2/13/2025Cerity Partners LLC78,101$156K0.0%+49.9%0.215% 2/12/2025O Shaughnessy Asset Management LLC40,404$81K0.0%N/A0.111% 2/11/2025Virtu Financial LLC14,862$30K0.0%N/A0.041% 2/11/2025Intech Investment Management LLC12,653$25K0.0%N/A0.035% Get the Latest News and Ratings for FBLG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for FibroBiologics and its competitors with MarketBeat's FREE daily newsletter. 2/7/2025Cascade Financial Partners LLC282,601$565K0.1%-6.6%0.803% 2/6/2025Raymond James Financial Inc.18,642$37K0.0%N/A0.053% 11/19/2024Barclays PLC39,958$123K0.0%+363.2%0.115% 11/16/2024Geode Capital Management LLC599,760$1.85M0.0%+90.0%1.706% 11/15/2024Barclays PLC39,958$123K0.0%+363.2%0.114% 11/15/2024Jane Street Group LLC11,852$37K0.0%N/A0.034% 11/15/2024State Street Corp475,837$1.47M0.0%+26.5%1.353% 11/13/2024The Manufacturers Life Insurance Company10,264$32K0.0%N/A0.029% 11/12/2024Charles Schwab Investment Management Inc.69,732$215K0.0%+5.2%0.198% 10/22/2024Symphony Financial Ltd. Co.23,772$76K0.0%N/A0.067% 8/14/2024Marshall Wace LLP16,702$83K0.0%-67.9%0.047% 8/12/2024Mercer Global Advisors Inc. ADV10,272$51K0.0%N/A0.029% 8/6/2024Fund Evaluation Group LLC1,055,105$5.27M0.3%N/A3.001% 8/6/2024 Cahaba Wealth Management Inc.14,702$73K0.0%N/A0.041% 8/1/2024Rhumbline Advisers23,057$115K0.0%N/A0.065% 7/31/2024Cascade Financial Partners LLC315,055$1.57M0.2%N/A0.882% 7/31/2024Concurrent Investment Advisors LLC35,283$176K0.0%N/A0.099% 7/26/2024Bank of New York Mellon Corp68,558$342K0.0%N/A0.192% 7/23/2024 RMR Wealth Builders37,360$186K0.0%N/A0.105% 7/18/2024 Saxon Interests Inc.21,214$106K0.1%N/A0.059% 7/17/2024 ERn Financial LLC31,819$159K0.0%N/A0.089% 7/15/2024Transform Wealth LLC133,890$668K0.1%N/A0.375% (Data available from 1/1/2016 forward) FBLG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FBLG shares? During the previous two years, 26 institutional investors and hedge funds held shares of FibroBiologics. The most heavily invested institutionals were Fund Evaluation Group LLC ($5.27M), Geode Capital Management LLC ($1.85M), State Street Corp ($1.47M), Transform Wealth LLC ($668K), Bank of New York Mellon Corp ($342K), Cascade Financial Partners LLC ($234K), and Charles Schwab Investment Management Inc. ($215K).Learn more on FibroBiologics' institutional investors. Which institutional investors have been buying FibroBiologics' stock? Of the 25 institutional investors that purchased FibroBiologics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fund Evaluation Group LLC ($1.06M), Cascade Financial Partners LLC ($315.06K), Geode Capital Management LLC ($284.05K), Transform Wealth LLC ($133.89K), State Street Corp ($99.79K), Bank of New York Mellon Corp ($68.56K), and Barclays PLC ($62.66K). How much institutional buying is happening at FibroBiologics? Institutional investors have bought a total of 2,280,368 shares in the last 24 months. This purchase volume represents approximately $9.56M in transactions. Which of FibroBiologics' major shareholders have been selling company stock? The following institutional investors have sold FibroBiologics stock in the last 24 months: Cascade Financial Partners LLC ($42.52K), and Marshall Wace LLP ($35.32K). How much institutional selling is happening at FibroBiologics? Institutional investors have sold a total of 77,843 shares in the last 24 months. This volume of shares sold represents approximately $236.53K in transactions. Related Companies CRBP Institutional Ownership HLVX Institutional Ownership TCRX Institutional Ownership CHRS Institutional Ownership CLYM Institutional Ownership ZNTL Institutional Ownership OKYO Institutional Ownership CLLS Institutional Ownership CRDL Institutional Ownership VXRT Institutional Ownership This page (NASDAQ:FBLG) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.